Deletion of Cd39/Entpd1 Results in Hepatic Insulin Resistance
Keiichi Enjyoji(Beth Israel Deaconess Hospital), Simon C. Robson(Beth Israel Deaconess Medical Center), David J. Friedman(Broad Institute), Masato Imai(Beth Israel Deaconess Medical Center), Chandrashekar Thukral(Beth Israel Deaconess Medical Center), Benjamin Blumel(Beth Israel Deaconess Medical Center), Eva Csizmadia(Beth Israel Deaconess Medical Center), Xiaofeng Sun(Lanzhou Petrochemical Polytechnic), Yan Wu(Beth Israel Deaconess Medical Center), Wissam Bleibel(Beth Israel Deaconess Medical Center), Ko Kotani(Beth Israel Deaconess Medical Center), Barbara B. Kahn(Beth Israel Deaconess Medical Center)
Cited by 101
Related Papers
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase
|Nature Medicine|2002|4.2k
Obesity and insulin resistance
|Journal of Clinical Investigation|2000|3.2k
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
|Cell Metabolism|2005|2.8k
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
|The Journal of Experimental Medicine|2007|2.4k